Company / Revenue per Share
Neogen Revenue per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$4.14
FY2024
5-year range
$4.14 / $8.57
FY2020-FY2024
Trend
-51.7%
vs FY2023
Sector context
#133 of 147
Health Care
What the data says
Among 147 Health Care companies, Neogen is in the bottom 10% for revenue per share. Revenue per Share has fluctuated over the past 9 years, ranging from $4.14 in FY2024 to $10.59 in FY2017.
Based on SEC 10-K filings.
4.14 in FY2024 with a 5-year CAGR of -12.5%.
Declined from $7.65 to $4.14 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -6.0%
- 5-Year CAGR
- -12.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 147This company $4.14 Sector average $127.83
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2024, revenue per share decreased 51.7% year-over-year.
- Ranks #133 out of 147 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $4.14 | -51.7% |
| FY2023 | $8.57 | +12.0% |
| FY2022 | $7.65 | +53.7% |
| FY2021 | $4.98 | -44.5% |
| FY2020 | $8.97 | +11.0% |
| FY2019 | $8.08 | -0.6% |
| FY2018 | $8.13 | -23.2% |
| FY2017 | $10.59 | +9.8% |
| FY2016 | $9.65 | +10.3% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026